0.3715
-0.0008
(-0.21%)
At close: 8:08:28 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-125,854
-315,021
-145,933
-82,232
81,602
Investing Cash Flow
134,512
153,657
89,116
-426,972
452,487
Financing Cash Flow
-506
122,749
46,776
-563
13,343
End Cash Position
129,066
113,688
155,700
171,223
678,393
Interest Paid Supplemental Data
--
54
104
94
135
Capital Expenditure
-376
-2,519
-38,741
-30,186
-3,994
Issuance of Capital Stock
--
48,407
--
--
37,829
Issuance of Debt
--
74,078
--
--
--
Repayment of Debt
-90
-484
-538
-5,892
-13,023
Free Cash Flow
-126,230
-317,540
-184,674
-112,418
77,608
12/31/2020 - 11/19/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NB11.F Vaxart, Inc.
0.4818
-1.79%
MBIO.CN MindBio Therapeutics Corp.
0.0200
+33.33%
ARTL Artelo Biosciences, Inc.
1.0000
-6.54%
ATXS Astria Therapeutics, Inc.
6.10
-5.28%
SCPX Scorpius Holdings, Inc.
0.1599
-6.49%
CTMX CytomX Therapeutics, Inc.
0.6503
-3.97%
ALLR Allarity Therapeutics, Inc.
0.8801
+10.19%
NKTR Nektar Therapeutics
0.8019
-4.54%
RENB Renovaro Inc.
0.8937
-9.05%
CDT Conduit Pharmaceuticals Inc.
1.1600
-3.33%